Memorial Sloan Kettering’s Library has assembled a practical guide to AI data sources that matter to clinicians and researchers: a curated list spanning cancer imaging, genomics, cardiac data, and more. The MSK Library’s page brings disparate resources into one place, then reminds users to appraise quality before building models. That last part is where many projects stumble. This piece explains what the guide includes and adds a field-tested checklist to help teams get value from MSK AI datasets without tripping over bias or compliance gaps.
What the MSK AI datasets guide actually offers
According to the MSK Library guide, the collection spans well-known sources across oncology and adjacent clinical domains. It links to the National Institutes of Health’s All of Us Researcher Workbench, a cloud platform where registered users can access tiered data, and The Cancer Genome Atlas through the GDC Data Portal for tumor genomics. For imaging, it highlights The Cancer Imaging Archive (TCIA), which hosts de-identified DICOM studies fit for segmentation, detection, and radiomics work. It also points to neuroscience and cardiac data via Brainlife.io and the Cardiac Atlas Project.
The guide’s framing is clear: these listings are resources, not endorsements. It cautions readers to assess provenance, de-identification, and fitness for purpose before training any model. That caveat is the difference between a promising proof of concept and a system that survives IRB, IT security, and clinical governance reviews.
Why curated dataset repositories matter in healthcare AI
Public datasets reduce time to a working baseline, especially when local data access is slow or governed by strict approvals. TCIA’s labeled cancer studies let teams prototype with standard cohorts before touching institutional PACS. TCGA enables feature discovery and model pretraining for mutation or survival prediction without negotiating dozens of individual data-use agreements.
Curation also supports compliance. The MSK Library’s emphasis on appraisal dovetails with the National Institutes of Health’s Data Management and Sharing Policy, which requires grant-funded researchers to plan for data handling and public sharing. Starting with reputable repositories makes it easier to explain data lineage, justify protections for controlled-access elements, and document re-use in a study’s DMS plan.
The other reason to start from curated sources is repeatability. When a team benchmarks against a named dataset, reviewers can replicate results and compare methods directly. That shared baseline shortens the path from a preprint to a study another lab can verify.
How to vet MSK Library datasets before you train
The guide urges caution. Here is a practical checklist that extends that advice and ties it to widely cited standards from regulators and standards bodies.
- Provenance and consent: Confirm who collected the data, under what protocol, and with which consent terms. For clinical use, align with your IRB. If re-use is restricted, document the limits in your project plan.
- De-identification method: Check the de-identification approach against HHS HIPAA guidance. Look for removal of direct identifiers, handling of facial features in imaging, and mitigation of re-identification via rare combinations.
- Label quality and inter-rater agreement: Inspect how labels were created. Were radiology labels reader-verified? Is there a reported kappa score or adjudication process? Weak labels often hide behind big sample sizes.
- Population coverage: Compare demographics and acquisition settings to your target population. If your hospital serves a different mix of ages, scanners, or disease subtypes, plan for domain adaptation.
- Data splits and leakage: Use patient-level splits and verify that near-duplicate studies or time-adjacent scans do not leak between train and test. This matters most in longitudinal oncology cohorts.
- Audit trails and documentation: Maintain a data sheet or model card linking back to the source, version, and any preprocessing. The FDA’s thinking on good machine learning practice for medical devices favors well-documented training and testing flows; see the agency’s AIML resources.
- Evaluation across sites: If available, test on an external site or scanner. Cross-site validation reduces the risk of overfitting to one institution’s protocols.
- Bias and performance by subgroup: Measure sensitivity and specificity across age, sex, and race when such fields are ethically and legally available, aligning with guidance on data quality and bias from standards groups like NIST’s AI Risk Management Framework.
Apply this checklist to any source surfaced by the guide. The goal is to turn a curated link into a defensible dataset pipeline that your clinical governance board can sign off on.
Getting value from MSK AI datasets without surprises
Teams often treat public data as a shortcut. It is more useful as a scaffold. Pretrain on TCIA images, then fine-tune on your hospital’s de-identified scans under an IRB protocol. Explore survival models on TCGA, then validate on a registry inside your cancer center. Use All of Us to test equity-aware performance measures, then check subgroup metrics in your local EHR extract. Anchoring work in MSK AI datasets cuts time to insight, yet the on-ramp to production still requires local evidence.
Think about governance early. If you intend to publish or share derived datasets, align your plan with the NIH DMS policy on day one. Document the version of each repository used, the exact cohort definitions, and any filtering. That paper trail saves cycles when a reviewer asks how you avoided leakage or handled rare labels.
Security and privacy deserve equal weight. Even when a source states it is de-identified, validate that claim against your risk model. DICOM headers, burned-in annotations, and linkable dates can slip through. Document a redaction pass and preserve the script so another team can reproduce it.
Where this leaves researchers and data teams
The MSK Library has done the tedious part—gathering dependable starting points—so researchers can spend less time hunting and more time modeling. The hard work that remains is disciplined appraisal and documentation. With a checklist-driven approach, MSK AI datasets become more than links. They become the backbone of workflows that stand up to audits, reproduce across sites, and improve patient care when models move beyond the lab. For more on this, see bloomberg.com and nytimes.com.
Related reading: Video Generation • AI Agents • AI Tools & Platforms